Release Details

SAN DIEGO, Oct. 25 -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will be presenting at the Salomon Smith Barney Citigroup 2002 Global Health Care Conference in New York at the Plaza Hotel on Monday, October 28, 2002 at 10:15AM Eastern Standard Time (7:15AM Pacific Standard Time) The presentation will be simultaneously webcast and can be accessed at http://www.veracast.com/ssb/2002/healthcare/41105362.cfm or through a link provided via the Company's website at http://www.neurocrine.com .

Gary Lyons, President and CEO of Neurocrine will discuss the Company's clinical development program for indiplon for the treatment of insomnia and will also discuss the Company's broad development pipeline and research programs. Viewers are encouraged to visit the website approximately 15 minutes prior to the presentation to download or install any necessary audio software. If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 658-7600 and ask for Claudia Jones or Elizabeth Foster. The presentation will be archived until Wednesday, November 13.

Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, malignant brain tumors and peripheral cancers, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, stroke, and certain female health disorders.

Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com .

Source: Neurocrine Biosciences, Inc.